{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:28Z","timestamp":1789143088855,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["BMBF 031L0219"],"award-info":[{"award-number":["BMBF 031L0219"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["031L0217A"],"award-info":[{"award-number":["031L0217A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.medj.2026.101262","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:14:15Z","timestamp":1786979655000},"page":"101262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concomitant lipid-lowering and anticoagulation therapy for recurrent venous thromboembolism prevention: A Bayesian meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7633-7877","authenticated-orcid":false,"given":"Harsini","family":"Raaja Sulochana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bindila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis T.","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros V.","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101262_bib1","article-title":"Drug Interactions Affecting Oral Anticoagulant Use","volume":"15","author":"Mar","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.medj.2026.101262_bib2","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2018-06-848747","article-title":"Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions","volume":"132","author":"Vazquez","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medj.2026.101262_bib3","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/eurheartj\/ehae361","article-title":"Lipid lowering for prevention of venous thromboembolism: a network meta-analysis","volume":"45","author":"Farmakis","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2026.101262_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as Antithrombotic Drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2026.101262_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","article-title":"Statins and blood coagulation","volume":"25","author":"Undas","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.medj.2026.101262_bib6","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.120.046397","article-title":"The Effect of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism","volume":"141","author":"Marston","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2026.101262_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2003.07.003","article-title":"Antiatherothrombotic effects of nicotinic acid","volume":"171","author":"Rosenson","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.medj.2026.101262_bib8","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jtha.2023.08.004","article-title":"Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism","volume":"21","author":"Dai","year":"2023","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101342","article-title":"Lipid Lowering Therapy: An Era Beyond Statins","volume":"47","author":"Abdul-Rahman","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.medj.2026.101262_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ejcts\/ezt181","article-title":"Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients","volume":"45","author":"Kuhn","year":"2014","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"key":"10.1016\/j.medj.2026.101262_bib11","unstructured":"Excellence, N.I.f.H.a.C. (2023). Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification."},{"key":"10.1016\/j.medj.2026.101262_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101262_bib13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2026.101262_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10557-023-07479-4","article-title":"Rivaroxaban Combined with Atorvastatin Inhibits Acute Pulmonary Embolism by Promoting the Expression of NRF2\/NQO1","volume":"38","author":"Chen","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.medj.2026.101262_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030364","article-title":"Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects","volume":"16","author":"Chung","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.medj.2026.101262_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70245","article-title":"Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation","volume":"34","author":"de Burgos-Gonz\u00e1lez","year":"2025","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.medj.2026.101262_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085401","article-title":"Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry","volume":"14","author":"Del Giorno","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.medj.2026.101262_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.15537","article-title":"Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility","volume":"20","author":"Delluc","year":"2022","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2022.03.014","article-title":"Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)","volume":"213","author":"Delluc","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.medj.2026.101262_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.21037\/apm-20-925","article-title":"Effects of atorvastatin combined with bivalirudin on coagulation function, cardiac function, and inflammatory factors of percutaneous coronary intervention in elderly patients with acute myocardial infarction","volume":"9","author":"Ding","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.medj.2026.101262_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.06.008","article-title":"Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?","volume":"120","author":"Douketis","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medj.2026.101262_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/10558450-000000000-00000","article-title":"Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"26","author":"Enajat","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.medj.2026.101262_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ane.13077","article-title":"Statins and the risk of bleeding in patients taking dabigatran","volume":"139","author":"Ho","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.medj.2026.101262_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00228-005-0986-6","article-title":"Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects","volume":"61","author":"Jindal","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2026.101262_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcpt.12998","article-title":"Statins do not Increase the Rate of Bleeding Among Warfarin Users","volume":"123","author":"Korhonen","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.medj.2026.101262_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51374-8","article-title":"Statin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort study","volume":"9","author":"Kronenberg","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2026.101262_bib27","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1177\/030006051204000508","article-title":"Absence of clinically relevant interactions between rivaroxaban--an oral, direct Factor Xa inhibitor--and digoxin or atorvastatin in healthy subjects","volume":"40","author":"Kubitza","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.medj.2026.101262_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjcard.2017.04.011","article-title":"Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus","volume":"120","author":"Kumagai","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.medj.2026.101262_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijcard.2016.11.245","article-title":"Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics","volume":"228","author":"Leonard","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.medj.2026.101262_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11239-024-03002-0","article-title":"Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2","volume":"57","author":"Mabuchi","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.medj.2026.101262_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40256-013-0029-0","article-title":"Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor","volume":"13","author":"Mendell","year":"2013","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.medj.2026.101262_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003135","article-title":"Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study","volume":"3","author":"Nguyen","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.medj.2026.101262_bib33","first-page":"e43","article-title":"The Effects of 3-Month Rosuvastatin Adjuvant Therapy on Post Thrombotic Syndrome following Deep Vein Thrombosis; a Randomized Clinical Trial","volume":"11","author":"Pishgahi","year":"2023","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.medj.2026.101262_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1024\/0301-1526\/a000507","article-title":"Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis","volume":"45","author":"San Norberto","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.medj.2026.101262_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0091270004268047","article-title":"No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran","volume":"44","author":"Sarich","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2026.101262_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjmed.2009.07.020","article-title":"Fibrate\/Statin initiation in warfarin users and gastrointestinal bleeding risk","volume":"123","author":"Schelleman","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medj.2026.101262_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jth.12604","article-title":"Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study","volume":"12","author":"Schmidt","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158130","article-title":"Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study","volume":"11","author":"Shin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2026.101262_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0091270005278224","article-title":"Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics","volume":"45","author":"Simonson","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2026.101262_bib40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10557-022-07346-8","article-title":"Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore","volume":"37","author":"Soh","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.medj.2026.101262_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.medj.2026.101262_bib42","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1160\/TH15-10-0775","article-title":"Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study","volume":"115","author":"Tagalakis","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.medj.2026.101262_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/gps.2688","article-title":"One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial","volume":"27","author":"Tendolkar","year":"2012","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.medj.2026.101262_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-022-00555-4","article-title":"Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study","volume":"23","author":"Uchida","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.medj.2026.101262_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jacl.2011.05.003","article-title":"Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment","volume":"5","author":"van Kuilenburg","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.medj.2026.101262_bib46","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00228-016-2138-6","article-title":"Statin use decreases coagulation in users of vitamin K antagonists","volume":"72","author":"van Rein","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2026.101262_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MBC.0000000000000968","article-title":"A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism","volume":"32","author":"Wang","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.medj.2026.101262_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-9560-12-26","article-title":"Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy","volume":"12","author":"Wells","year":"2014","journal-title":"Thromb. J."},{"key":"10.1016\/j.medj.2026.101262_bib49","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.3399\/BJGP.2024.0349","article-title":"Potential interactions between direct oral anticoagulants and atorvastatin\/simvastatin: a cohort and case-crossover study","volume":"75","author":"Wong","year":"2025","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.medj.2026.101262_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038668","article-title":"Concomitant Drug Interactions With Non-Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation","volume":"14","author":"Wong","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.medj.2026.101262_bib51","article-title":"Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants-A nationwide cohort study","volume":"9","author":"Wu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.medj.2026.101262_bib52","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1007\/s00415-016-8283-0","article-title":"Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study","volume":"263","author":"Yang","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.medj.2026.101262_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-9150(98)00144-0","article-title":"Effects of lipids and lipoproteins on thrombosis and rheology","volume":"140","author":"Rosenson","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.medj.2026.101262_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/ATVBAHA.123.318286","article-title":"Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting","volume":"44","author":"Zhang","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.medj.2026.101262_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0304-4157(98)00018-5","article-title":"Lipid-protein interactions in blood coagulation","volume":"1376","author":"Zwaal","year":"1998","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"key":"10.1016\/j.medj.2026.101262_bib56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cvr\/cvab017","article-title":"Relationship between lipoproteins, thrombosis, and atrial fibrillation","volume":"118","author":"Ding","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.medj.2026.101262_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12944-024-02315-6","article-title":"Identification of oxylipins and lipid mediators in pulmonary embolism","volume":"23","author":"Chen","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.medj.2026.101262_bib58","doi-asserted-by":"crossref","first-page":"e259467","DOI":"10.1001\/jamanetworkopen.2025.9467","article-title":"Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism","volume":"8","author":"Siniscalchi","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.medj.2026.101262_bib59","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.medj.2026.101262_bib60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","article-title":"Statins, fibrates, and venous thromboembolism: a meta-analysis","volume":"31","author":"Squizzato","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2026.101262_bib61","series-title":"StatPearls, (StatPearls Publishing Copyright \u00a9 2025","article-title":"Statin Medications","author":"Sizar","year":"2025"},{"key":"10.1016\/j.medj.2026.101262_bib62","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1038\/s41598-021-87528-w","article-title":"The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2026.101262_bib63","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5551\/jat.48603","article-title":"The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials","volume":"26","author":"Daida","year":"2019","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.medj.2026.101262_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2018.02.035","article-title":"Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials","volume":"271","author":"Zaccardi","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.medj.2026.101262_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9150(02)00387-8","article-title":"Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation","volume":"167","author":"Bea","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.medj.2026.101262_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232719","article-title":"Statins Effects on Blood Clotting: A Review","volume":"12","author":"Siniscalchi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.medj.2026.101262_bib67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001721-200309000-00010","article-title":"Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation","volume":"14","author":"Shi","year":"2003","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.medj.2026.101262_bib68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2024.02.024","article-title":"Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry","volume":"236","author":"Siniscalchi","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.medj.2026.101262_bib69","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/jth.15753","article-title":"Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism","volume":"20","author":"Siniscalchi","year":"2022","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2019.07.028","article-title":"Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry","volume":"68","author":"Siniscalchi","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.medj.2026.101262_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.766377","article-title":"Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.medj.2026.101262_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.899906","article-title":"An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve","volume":"9","author":"Cao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.medj.2026.101262_bib73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-Dependent Effects of Statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.medj.2026.101262_bib74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jtha.2022.12.008","article-title":"Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis","volume":"21","author":"Caiano","year":"2023","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105735","article-title":"Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms","volume":"122","author":"Liberale","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.medj.2026.101262_bib76","doi-asserted-by":"crossref","first-page":"II-18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, Immunity, and HMG-CoA Reductase Inhibitors","volume":"109","author":"Sch\u00f6nbeck","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2026.101262_bib77","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cccn.2005.04.032","article-title":"Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease","volume":"360","author":"Ndrepepa","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.medj.2026.101262_bib78","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jth.12680","article-title":"C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vain grafts","volume":"12","author":"Ji","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.medj.2026.101262_bib79","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2026.101262_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvae034","article-title":"Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials","volume":"120","author":"Xie","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.medj.2026.101262_bib81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of Statin Therapy on C-Reactive Protein LevelsThe Pravastatin Inflammation\/CRP Evaluation (PRINCE): A Randomized Trial and Cohort Study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2026.101262_bib82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjcard.2008.09.090","article-title":"Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy","volume":"103","author":"Pearson","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.medj.2026.101262_bib83","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH14-11-0937","article-title":"Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials","volume":"114","author":"Sahebkar","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.medj.2026.101262_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12944","article-title":"Clinical effects of antiplatelet drugs and statins on D-dimer levels","volume":"48","author":"Schol-Gelok","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.medj.2026.101262_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13130","article-title":"A revised systematic review and meta-analysis on the effect of statins on D-dimer levels","volume":"49","author":"Schol-Gelok","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.medj.2026.101262_bib86","article-title":"forplo: Flexible Forest Plots","author":"ten Cate","year":"2022","journal-title":"R package (version 0.2.5.)"},{"key":"10.1016\/j.medj.2026.101262_bib87","unstructured":"Cate, V.t. (2022). Forplo : Flexible Forest Plots."},{"key":"10.1016\/j.medj.2026.101262_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: An R Package for Bayesian Multilevel Models Using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.medj.2026.101262_bib89","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.medj.2026.101262_bib90","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"354","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.medj.2026.101262_bib91","unstructured":"GA Wells, B.S., D O'Connell, J Peterson, V Welch, M Losos, P Tugwell, (2011). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.medj.2026.101262_bib92","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"10.1016\/j.medj.2026.101262_bib93","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 6: Choosing effect measures and computing estimates of effect","author":"Julian PT Higgins","year":"2024"},{"key":"10.1016\/j.medj.2026.101262_bib94","article-title":"CompSysMed-Mainz\/Concomitant_LLT_AC_systematic_review_and_meta_analysis: Analysis scripts updated for publication (Version v1.1.0) [Computer software]","author":"Harsini","year":"2026","journal-title":"Zenodo"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:33:42Z","timestamp":1789140822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026002655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666634026002655"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101262","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant lipid-lowering and anticoagulation therapy for recurrent venous thromboembolism prevention: A Bayesian meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101262"}}